MY110416A - Composition for the treatment of schizophrenia. - Google Patents

Composition for the treatment of schizophrenia.

Info

Publication number
MY110416A
MY110416A MYPI90002121A MYPI19902121A MY110416A MY 110416 A MY110416 A MY 110416A MY PI90002121 A MYPI90002121 A MY PI90002121A MY PI19902121 A MYPI19902121 A MY PI19902121A MY 110416 A MY110416 A MY 110416A
Authority
MY
Malaysia
Prior art keywords
schizophrenia
treatment
composition
neuroleptica
propynyl
Prior art date
Application number
MYPI90002121A
Inventor
Jozsef Knoll Dr
Ede Frecska Dr
Goswami Utpal Dr
Mihaly Arato Dr
Arpad Bela Dr
Andras Perenyi Dr
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek
Priority to MYPI90002121A priority Critical patent/MY110416A/en
Publication of MY110416A publication Critical patent/MY110416A/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THERE PRESENT INVENTION IS RELATED TO A PHARMACEUTICAL COMPOSITION SUITABLE FOR THE TREATMENT OF SCHIZOPHRENIA COMPRISING AN ACID ADDITION SALT OF (1)-N-(1-PHENYL-ISOPROPYL)-N-METHYL-1-PROPYNYL-AMINE IN A THERAPEUTICALLY EFFECTIVE AMOUNT AND OPTIONALLY ONE OR MORE NEUROLEPTICA AND PHARMACEUTICALLY ACCEPTABLE CARRIERS, AND OTHER EXCIPIENTS.
MYPI90002121A 1990-12-03 1990-12-03 Composition for the treatment of schizophrenia. MY110416A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI90002121A MY110416A (en) 1990-12-03 1990-12-03 Composition for the treatment of schizophrenia.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI90002121A MY110416A (en) 1990-12-03 1990-12-03 Composition for the treatment of schizophrenia.

Publications (1)

Publication Number Publication Date
MY110416A true MY110416A (en) 1998-05-30

Family

ID=79553826

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI90002121A MY110416A (en) 1990-12-03 1990-12-03 Composition for the treatment of schizophrenia.

Country Status (1)

Country Link
MY (1) MY110416A (en)

Similar Documents

Publication Publication Date Title
HK1003978A1 (en) Composition for the treatment of schizophrenia
RU94041223A (en) Agent for motoneuron disease treatment
UA41446C2 (en) Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition
TR199801180T2 (en) New compounds with analgesic effect.
MY132705A (en) Novel compounds with analgesic effect
BR9609063A (en) Dinucleotides useful for the treatment of lung diseases
DE69329400T2 (en) Composition containing L-dopa ester
UA41355C2 (en) Agent for treating neuro-aids
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
ES2161238T3 (en) USE OF 2-PHENYL-3-AROILBENZOTIOPHENES FOR THE PREPARATION OF A MEDICINAL PRODUCT TO INHIBIT ANGIOGENESIS AND ANGIOGENIC DISEASES.
ES2160643T3 (en) COMPOSITIONS CONTAINING G-CSF AND PROTEIN OF UNION TO TNF.
CA2042972A1 (en) Treatment of ocular hypertension with a synergistic combination for ocular administration
HU9303000D0 (en) Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
TR199801184T2 (en) New compounds with analgesic action.
MY110416A (en) Composition for the treatment of schizophrenia.
MY133438A (en) Morpholinobenzamide salts
HK1013622A1 (en) Pharmaceutical lysine-containing polypeptide compositions and the use thereof
IL126795A (en) Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
CA2135752A1 (en) Use of (E)-2-(p-Fluorophenethyl)-3-Fluoroallylamine in the Treatment of Alzheimer's Disease
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
CA2154485A1 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
NO961180L (en) Transdermal device containing (E) -2- (p-fluorophenethyl) -3-fluoroallylamine for the treatment of Alzheimer's disease